NCT00327470 - An Open Label Trial to Investigate Macugen for the Preservation of Visual Function in Subjects With Neovascular AMD | Biotech Hunter

Enrollment

288

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions

Age Related Macular Degeneration (AMD)Macular DegenerationChoroidal Neovascularization (CNV)

Interventions

DRUG

Pegaptanib Sodium 0.3 mg

Pegaptanib Sodium dosed every 6 weeks in affected eye.

Trial Locations (58)

1020

Pfizer Investigational Site, Brussels

1070

Pfizer Investigational Site, Brussels

2600

Pfizer Investigational Site, Glostrup Municipality

3000

Pfizer Investigational Site, Coimbra

4000

Pfizer Investigational Site, Liège

4200

Pfizer Investigational Site, Porto

13008

Pfizer Investigational Site, Marseille

15705

Pfizer Investigational Site, Santiago de Compostela

20132

Pfizer Investigational Site, Milan

20157

Pfizer Investigational Site, Milan

34098

Pfizer Investigational Site, Istanbul

34390

Pfizer Investigational Site, Istanbul

37044

Pfizer Investigational Site, Tours

42055

Pfizer Investigational Site, Saint-Etienne

44093

Pfizer Investigational Site, Nantes

44137

Pfizer Investigational Site, Dortmund

46014

Pfizer Investigational Site, Valencia

48145

Pfizer Investigational Site, Münster

50134

Pfizer Investigational Site, Florence

54035

Pfizer Investigational Site, Nancy

60020

Pfizer Investigational Site, Ancona

70124

Pfizer Investigational Site, Bari

70211

Pfizer Investigational Site, Kuopio

75015

Pfizer Investigational Site, Paris

75571

Pfizer Investigational Site, Paris

79106

Pfizer Investigational Site, Freiburg im Breisgau

A-8036

Pfizer Investigational Site, Graz

A-6020

Pfizer Investigational Site, Innsbruck

A-1030

Pfizer Investigational Site, Vienna

A-1180

Pfizer Investigational Site, Vienna

V8R 1J8

Pfizer Investigational Site, Victoria

V8V 4X3

Pfizer Investigational Site, Victoria

B3H 2Y9

Pfizer Investigational Site, Halifax

N6A 4G5

Pfizer Investigational Site, London

M5T 2S8

Pfizer Investigational Site, Toronto

H3A 1A1

Pfizer Investigational Site, Montreal

775 20

Pfizer Investigational Site, Olomouc

128 08

Pfizer Investigational Site, Prague

140 00

Pfizer Investigational Site, Prague

169 02

Pfizer Investigational Site, Prague

06120

Pfizer Investigational Site, Halle

115 27

Pfizer Investigational Site, Athens

155 62

Pfizer Investigational Site, Athens

80-952

Pfizer Investigational Site, Gdansk

40-952

Pfizer Investigational Site, Katowice

61-848

Pfizer Investigational Site, Poznan

03-709

Pfizer Investigational Site, Warsaw

1169-019

Pfizer Investigational Site, Lisbon

1169-0940

Pfizer Investigational Site, Lisbon

03016

Pfizer Investigational Site, Alicante

08025

Pfizer Investigational Site, Barcelona

06100

Pfizer Investigational Site, Ankara

EH3 9NA

Pfizer Investigational Site, Edinburgh

AB25 2ZN

Pfizer Investigational Site, Aberdeen

BT12 6BA

Pfizer Investigational Site, Belfast

BS1 2LX

Pfizer Investigational Site, Bristol

LS9 7TF

Pfizer Investigational Site, Leeds

SO16 6YD

Pfizer Investigational Site, Southampton